Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer
- PMID: 34793357
- DOI: 10.1097/SLA.0000000000005317
Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer
Conflict of interest statement
The author reports no conflicts of interest.
Comment on
-
Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.Ann Surg. 2022 Mar 1;275(3):415-421. doi: 10.1097/SLA.0000000000005249. Ann Surg. 2022. PMID: 35120060
References
-
- Versteijne E, Suker M, Groothuis K, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial. J Clin Oncol 2020; 38:1763–1773.
-
- da Costa WL, Tran Cao HS, Portuondo JI, et al. Hospital clinical staging accuracy for upper gastrointestinal malignancy. J Surg Oncol 2020; 122:1630–1638.
-
- Baugh KA, Tran Cao HS, van Buren G, et al. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery 2019; 165:307–314.
-
- da Costa Jr. WL, Cao HST, Gu X, et al. Bayesian approach to understand the association between treatment down-staging and survival for patients with pancreatic adenocarcinoma. Ann Surg . 2022;275:415–421.
-
- Becerra AZ, Wexner SD, Dietz DW, et al. Nationwide heterogeneity in hospital-specific probabilities of rectal cancer understaging and its effects on outcomes. Ann Surg Oncol 2018; 25:2332–2339.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
